Benitec Biopharma (BNTC) Depreciation and Depletion (2019 - 2023)
Benitec Biopharma (BNTC) reported Depreciation and Depletion of $19000.0 for Q3 2023, down 54.76% on a YoY basis from $42000.0 in Q3 2022, and down 54.76% sequentially from $42000.0 in Q3 2022.
Benitec Biopharma (BNTC) Depreciation and Depletion (2019 - 2023) Analysis & Trends
Benitec Biopharma (BNTC) has 5 years of Depreciation and Depletion data on file, last reported at $19000.0 in Q3 2023.
- For the quarter ending Q3 2023, Depreciation and Depletion fell 54.76% year-over-year to $19000.0; the trailing twelve-month figure through Sep 2023 stood at $121000.0 (down 22.93% YoY), and the FY2022 full-year result was $167000.0, down 27.71% from the prior year.
- Depreciation and Depletion declined to $19000.0 in Q3 2023, from $42000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $67000.0 in Q4 2020 to a low of -$105000.0 in Q2 2020.
- A 5-year average of $36000.0 and a median of $51000.0 in 2019 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 149.52% in 2021 and sank 88.46% in 2022, its largest moves.
- Tracing BNTC's Depreciation and Depletion over 5 years: stood at $51000.0 in 2019, then soared by 31.37% to $67000.0 in 2020, then retreated by 17.91% to $55000.0 in 2021, then declined by 23.64% to $42000.0 in 2022, then slumped by 54.76% to $19000.0 in 2023.
- Business Quant data shows BNTC's Depreciation and Depletion at $19000.0 in Q3 2023, $42000.0 in Q3 2022, and $6000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Sep 30, 2020 | 45,000.00 |
| Sep 30, 2020 | 45,000.00 |